Gujarat Themis Biosyn Ltd share price logo

Gujarat Themis Biosyn Ltd

NSE: GUJTHEM

BSE: 506879

Small Cap

Pharma Sector

₹411.30

-19.15

(-4.45%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

What are INDmoney investors doing with Gujarat Themis Biosyn shares?

Based on platform-user behaviour - not analyst opinion or company fundamentals.

Search interest on INDmoney

+208%

Searches for Gujarat Themis Biosyn on INDmoney have increased by 208% over the last 30 days.

Average holding period of indmoney investors

38 days

INDmoney investors hold Gujarat Themis Biosyn shares for an average of 38 days.

Key Events for Gujarat Themis Biosyn

Last Dividend Declared

₹0.67 per share, declared on 20/05/2025

View Dividend History

Gujarat Themis Biosyn Stock Performance

as on September 16, 2026 at 6:41 pm IST

  • Day's Low

    Day's High

    ₹401.95
    ₹427.95
    downward going graph

    2.27%

    Downside

    4.05%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹225.05
    ₹479.00
    downward going graph

    45.28%

    Downside

    16.46%

    Upside

    downward going graph

Gujarat Themis Biosyn share price movements today

Previous Close
₹430.45
Open
₹410.75
Volume
2.58L
Upper Circuit
₹516.50
Lower Circuit
₹344.40
Day's Low - High
₹401.95 - ₹427.95
52 Week Low - High
₹225.05 - ₹479.00

Gujarat Themis Biosyn Historical Returns

1 Month Return
+ 22.55 %
3 Month Return
+ 13.7 %
1 Year Return
+ 12.9 %
3 Year Return
+ 266.78 %
5 Year Return
+ 554.08 %

Gujarat Themis Biosyn Fundamentals

as on September 16, 2026 at 1:11 pm IST

Market Cap

₹5,602.38 Cr

Return on Equity (ROE)

17.41

PE Ratio (TTM)

0

Return on capital employed (ROCE)

18.05

Industry PE ratio

-

Beta (LTM)

1.61

P/B Ratio

8.61

Dividend Yield

0

PEG Ratio

0

Quarterly Earnings Growth YOY

22.19

EPS (TTM)

0

Book Value

0

Gujarat Themis Biosyn Technical Analysis

Track how Gujarat Themis Biosyn technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bearish

Moving Averages

Bearish

Neutral

Bullish

Bullish

Oscillators

Bearish

Neutral

Bullish

Bearish

Overall

Bearish8
Bullish5
Neutral2

Oscillators

Name

Value

Action

MACD level (12,26)
0.31
Bearish
CCI (20)
176.68
Bearish
RSI (14)
47.6
Neutral
Momentum (10)
-0.9
Bearish
ADI (14)
51.51
Bearish
Ultimate Oscillator (7,14,28)
40.08
Neutral

Moving Averages

Name

Value

Action

SMA (20)
411.53
Bearish
EMA (20)
411.59
Bearish
VWMA (20)
411.84
Bearish
SMA (50)
410.95
Bullish
EMA (50)
410.97
Bullish
SMA (200)
409.9
Bullish
EMA (200)
411.49
Bearish
KAMA (200)
410.22
Bullish
DEMA (200)
408.6
Bullish

Gujarat Themis Biosyn Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Gujarat Themis Biosyn with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Gujarat Themis Biosyn Ltd image
Gujarat Themis Biosyn Ltd
NA5,602.38110.82%0.0046165
Bacil Pharma Ltd image
Bacil Pharma Ltd
NA29.1947.69%0.001NA
Concord Biotech Ltd image
Concord Biotech Ltd
BUY15,409.9711.25%0.502591,054
Beryl Drugs Ltd image
Beryl Drugs Ltd
NA11.7921.54%0.00-121
Natco Pharma Ltd image
Natco Pharma Ltd
HOLD14,671.79-3.06%0.541,3714,078
See all

Gujarat Themis Biosyn Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Jun 2025
Mar 2026
Jun 2026
Sales
35.87
44.23
43.79
Other Income
0.27
0.92
0.13
Total Income
36.15
45.15
43.92
Expenses
21.95
24.87
23
Operating Profit
13.92
19.36
20.79
Operating Profit Margin %
38.81%
43.77%
47.48%
Profit Before Interest, Tax and Depreciation
14.2
20.28
20.93
Interest
0.04
1.91
1.79
Depreciation
2.03
4.04
3.97
Profit Before Tax
12.13
14.33
15.17
Tax Paid
3.06
3.45
4.1
Profit After Tax
9.06
10.89
11.07
Total Net profit including share of profit / Loss from associate company
9.06
10.89
11.07
EPS
0.83
1
1.02
Actual EPS
0.83
1
1.02
Adjusted EPS
0.83
1
1.02
Diluted EPS
0.83
1
1.02

Gujarat Themis Biosyn Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2026
Sales
165.82
Other Income
2.43
Total Income
168.25
Expenses
90.29
Operating Profit
75.53
Operating Profit Margin %
45.55%
Profit Before Interest, Tax and Depreciation
77.96
Interest
2.95
Depreciation
12.92
Profit Before Tax
62.09
Tax Paid
15.41
Profit After Tax
46.68
Total Net profit including share of profit / Loss from associate company
46.68
EPS
4.28
Actual EPS
4.28
Adjusted EPS
4.28
Diluted EPS
4.28

Gujarat Themis Biosyn Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Cash from Operating Activities
3.91
2.8
5.59
0.69
0.63
10.53
40.31
39.48
64.21
91.03
48.78
Cash Flow from Investing Activities
-0.78
-2.51
-1.03
-5.76
-2.98
-2.25
-29.83
-20.4
-55.2
-111.82
-172.27
Cash Flow from Financing Activities
-3.14
-0.19
-3.79
5.29
2.1
-5.17
-14
-13.28
-8.59
26.01
114.93
Net Cash Flow
-0.01
0.1
0.76
0.23
-0.26
3.12
-3.51
5.79
0.41
5.22
-8.57

Gujarat Themis Biosyn Stock Shareholding Pattern

Numbers in percentages

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Feb 2025
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Aug 2026
Promoters
70.86%
70.86%
70.86%
70.86%
70.86%
70.86%
70.86%
70.86%
70.86%
70.86%
70.86%
70.86%
59.33%
DII
0.02%
0.82%
1.19%
1.17%
1.17%
1.16%
1.17%
1.17%
1.17%
1.17%
1.18%
1.18%
13.79%
FII
0%
1.05%
1.44%
1.49%
1.42%
0%
1.91%
2.51%
2.95%
1.96%
1.8%
1.77%
4.93%
Public
28.23%
27.26%
26.52%
26.47%
26.54%
26.48%
26.05%
25.45%
25.01%
26%
26.16%
26.19%
21.95%
Total Outstanding Shares
7,26,43,510
7,26,43,510
7,26,43,510
10,89,65,265
10,89,65,265
10,89,65,265
10,89,65,265
10,89,65,265
10,89,65,265
10,89,65,265
10,89,65,265
10,89,65,265
13,01,51,705
Total Shareholders
28,655
29,576
30,280
31,271
30,934
30,436
30,673
28,945
28,319
27,325
26,886
27,010
26,899

Gujarat Themis Biosyn Corporate Actions

View detailed summary of the earnings and dividend history of Gujarat Themis Biosyn.

  • Gujarat Themis Biosyn Ltd Earnings Results

    Gujarat Themis Biosyn Ltd’s net profit jumped 22.19% since last year same period to ₹11.07Cr in the Q1 2026-2027. On a quarterly growth basis, Gujarat Themis Biosyn Ltd has generated 1.65% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Gujarat Themis Biosyn Ltd Dividends May,2025

    In the quarter ending March 2025, Gujarat Themis Biosyn Ltd has declared dividend of ₹0.67 per share on 20 May 2025 - translating a dividend yield of 0.16%.

    Read More about Dividends

Indices Featuring Gujarat Themis Biosyn Stock

Check stock indices that include Gujarat Themis Biosyn.

BSE Healthcare

₹50,385.79

-93.02 (▲0.18%)

Insights on Gujarat Themis Biosyn Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 1.16% to 9.66% in Aug 2026 quarter

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 1.77% to 4.93% in Aug 2026 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, GUJTHEM stock has moved up by 22.6%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 26.19% to 21.95% in Aug 2026 quarter

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 70.86% to 59.33% in Aug 2026 quarter

About Gujarat Themis Biosyn Ltd

GTBL was established in Dec.81 as a public limited company. Starting with the manufacturing of antibiotic erythromycin, it obtained licence in 1990 to produce bulk drugs like rifampicin, cephalexin, and griseofulvin with their formulations. From 1991, it faced several issues, thus making it a BIFR (Board of Industrial and Financial Reconstruction) case. It was then taken over by a group of investors – Lyka Labs, Themis Chemicals, Kopran, Cadila, and Yuhan Corporation (South Korea). In 1995-1996, they increased their paid up capital to Rs 11.60 crores after allotment of 350000 equity shares of Rs 10 each at a premium of Rs 20 per share to the financial institutions. This was followed by an increase in the installed capacity of rifamycinS to 90 mtpa and expansion of rifampicin to maximum capacity of 120 mtpa. They further launched a wide range of antituberculosis products and other antibiotics. They are focused on further diversifying and expanding their existing products and capacities with the scope to reduce production costs and increase turnover.

Revenue: ₹43.79Cr as on June 2026 (Q1 FY27)
Net Profit: ₹11.07Cr as on June 2026 (Q1 FY27)
Listing date: 01 Jun, 1995
Chairperson Name: Dinesh S Patel
OrganisationGujarat Themis Biosyn Ltd
HeadquartersMumbai
IndustryPharmaceuticals
CEODinesh S Patel
E-voting on sharesClick here to vote

FAQs

What is Gujarat Themis Biosyn share price today?

Gujarat Themis Biosyn share price today stands at ₹411.3 as on . Gujarat Themis Biosyn share today touched a day high of ₹427.95 and a low of ₹401.95.

What is the 52 week high and 52 week low range for Gujarat Themis Biosyn share?

Gujarat Themis Biosyn touched a 52 week high of ₹479 and a 52 week low of ₹225.05. Gujarat Themis Biosyn share price today i.e. is trending at ₹411.3, which is -14.13% down from its 52 week high and 82.76% up from its 52 week low.

What is Gujarat Themis Biosyn's market capitalisation today?

Gujarat Themis Biosyn market capitalisation is ₹5,602.38 Cr as on .

How to buy Gujarat Themis Biosyn shares?

To buy Gujarat Themis Biosyn shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for GUJTHEM or Gujarat Themis Biosyn Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Gujarat Themis Biosyn shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Gujarat Themis Biosyn trading volume today?

Gujarat Themis Biosyn trading volume is 2.58L as on . This means that 2.58L shares of Gujarat Themis Biosyn were bought and sold on the stock market during today's trading session.